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Abstract
Monitoring tissue hypoxia in critically ill patients is a challenging task.
Tissue PCO2 has long been proposed as a marker of tissue hypoxia,
although there is considerable controversy on whether the rise in
CO2 with hypoxia is caused by anaerobic metabolism and excess
CO2 production or by the accumulation of aerobically produced CO2
in the setting of blood flow stagnation. The prevention of increases in
intestinal PCO2 in aggressively resuscitated septic animals supports
the notion that tissue CO2 accumulation is a function of decreases in
blood flow, not of tissue hypoxia.
Hypotension is strongly associated with poor patient outcome,
and reversing this condition clearly should be a primary
therapeutic goal when treating patients in the early stages of
shock. Potent inotropic and vasoconstrictor agents are de
rigueur in the treatment of shock. The therapeutic goal is to
maintain the mean arterial pressure at levels above 60 mmHg,
a value thought to be the minimal pressure head required for
coronary and renal perfusion [1]. Our predicament is how best
to determine the mean arterial pressure level that will result in
optimal tissue perfusion in a given patient. In other words, is a
mean arterial pressure of 60 mmHg sufficient to assure
adequate perfusion to all organs? In some patients this
accepted minimal mean arterial pressure may not suffice to
insure adequate tissue perfusion. Should we aim for higher, or
perhaps even lower, mean arterial pressure values?
Catecholamines, while extremely useful in treating decreases
in cardiac output, may produce an unwelcome increase in
myocardial O2 consumption in cardiogenic shock, or may
impede blood flow to oxygen-starved tissues in hypovolemic
shock [2]. In septic shock, the balance between the positive
and the negative effects of vasopressor and inotropic agents
are even more difficult to discern [3].
A reliable and practical method to detect the onset of tissue
hypoxia in critically ill patients would be an invaluable tool in
guiding the timing and aggressiveness of resuscitation efforts.
Finding such a tool has bedeviled clinical investigators for
many years. Given our present level of technology, our options
in determining the adequacy of tissue oxygenation in the
clinical setting remain limited. Direct measures of tissue
oxygen concentration are not sufficient to characterize the
complex interaction between cellular energy requirements and
oxygen supply. More complex technology, such as magnetic
resonance spectroscopy and near-infrared spectroscopy are
either insensitive or impractical in the clinical setting.
A great deal of thinking has been devoted in the past to the
relationship of systemic measures of O2 delivery to O2
consumption [4]. Enthusiastic acceptance of the
‘supranormal’ O2 delivery concept, produced by the infusion
of fluid volume, inotropic agents and blood products [5], has
been tempered by studies finding no efficacy [6], or even
increased mortality [7], with this approach. Other clinical
studies, however, have shown improved survival in individuals
when treated immediately upon their arrival at the emergency
department with a protocol designed to increase O2 delivery
[8]. It appears that early efforts at resuscitation are critical to
survival, whereas delays in restoring adequate O2 delivery
may result in an ischemia-reperfusion-type phenomenon and
in greater mortality [9].
Measuring tissue PCO2 with a gastric tonometer [10] or a
sublingual tonometer [11,12] has been proposed as a
physiologically sound method of detecting decreases in
organ perfusion. Although numerous clinical and experimental
studies show a strong correlation between increases in tissue
PCO2 and poor patient outcome, gastric tonometry or
sublingual tonometry have encountered variable clinical
acceptance. Technical difficulties certainly have dampened
the initial enthusiasm for PCO2 tonometry, but a more
challenging obstacle to the widespread use of this
technology has been an inadequate understanding of the
mechanism(s) that result in tissue CO2 accumulation. A
crucial issue regarding the physiology of tissue CO2
accumulation is whether the rise in tissue PCO2 results from
decreases in cellular O2 delivery (or metabolism by
mitochondria) or from decreases in blood flow and the
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accumulation of ‘aerobic’ CO2 generated in the tricarboxylic
acid cycle [13].
Dubin and colleagues [14] explored this issue in the past by
subjecting experimental animals to decreases in O2 delivery
produced by lowering flow (ischemic hypoxia) or by lowering
arterial oxygen saturation (hypoxic hypoxia). There were
increases in intestinal venous PCO2 with ischemic hypoxia but
not with hypoxic hypoxia. Given that both preparations
presumably experienced similar degrees of tissue hypoxia, this
finding suggests that blood flow, not dysoxia, is the primary
determinant of increases in tissue PCO2. This conclusion,
moreover, was in consonance with the results obtained by
Vallet and colleagues [15] in isolated dog skeletal muscle.
In the current issue of Critical Care, Dubin and colleagues
[16] extend their findings by testing the hypothesis that
increasing intestinal blood flow prevents a rise in tissue
PCO2 in septic animals. They subjected two groups of sheep
to lipopolysaccharide infusion. One group received intra-
venous fluids at a rate that maintained baseline intestinal
blood flow. The other group was aggressively fluid
resuscitated, resulting in increases of 50% in intestinal blood
flow over basal conditions. An additional group of animals
served as a normal control. The intramucosal-to-arterial PCO2
difference (∆PCO2) rose in the first group, whereas volume
expansion prevented increases in ∆PCO2 in the aggressively
resuscitated group. Of interest, metabolic acidosis as
evidenced by a widening of the anion gap was greater in the
resuscitated group.
The avoidance of increases in tissue PCO2 in this model of
resuscitated sepsis supports the notion that hypoperfusion,
not tissue hypoxia, is the mechanism responsible for the
accumulation of CO2 in tissues. This finding provides
experimental validity to the concept developed in a mass
transport model of tissue CO2 exchange [17], in which
increases in tissue and venous blood CO2 concentration are
shown to be markers of regional hypoperfusion and not of
tissue hypoxia.
The mechanism responsible for the increased anion-gap
acidosis due to unmeasured anions in the resuscitated
animals cannot be ascertained from the measurements
obtained in this study. It is conceivable that resuscitation with
normal saline may have produced local tissue hypoxia, the
result of O2 radical species production. Measurements of
intestinal lactate production would have been helpful in
answering this question by establishing the degree of
anerobiasis in the resuscitated animals.
The study of Dubin and colleagues is another milepost in our
understanding of the mechanisms that govern increases in
tissue PCO2 during hypoxic and septic conditions. Since
changes in tissue PCO2 are likely to be determined by
alterations in blood flow, this may explain why gastric mucosal
PCO2 improves with greater cardiac output but not with
increases in O2-carrying capacity produced by blood
transfusions [18].
I believe that now is the time to renew our interest in clinical
measures of tissue PCO2, as we understand further the
clinical importance of gastric and sublingual tonometry as
markers of regional tissue perfusion.
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